Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Open Label Phase-II Clinical Trial With or Without Infusion of Plasma From Subjects After Convalescence of SARS-CoV-2 Infection in High-Risk Patients With Confirmed Severe SARS-CoV-2 Disease

NCT05200754 is registered in ClinicalTrials.gov with Carsten Müller-Tidow as lead sponsor.

NCT NCT05200754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05200754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Open Label Phase-II Clinical Trial With or Without Infusion of Plasma From Subjects After Convalescence of SARS-CoV-2 Infection in High-Risk Patients With Confirmed Severe SARS-CoV-2 Disease
Lead sponsor
Carsten Müller-Tidow
Phase
Phase 2
Overall status
Unknown status
Start date
September 3, 2020
Completion date
June 30, 2022
Enrollment
174 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection